Smith R, Mihalik A, Akula N, Auluck P, Marenco S, Raznahan A
bioRxiv. 2025; .
PMID: 39990369
PMC: 11844519.
DOI: 10.1101/2025.02.14.638357.
Lauer L, Rivas M
bioRxiv. 2025; .
PMID: 39896616
PMC: 11785203.
DOI: 10.1101/2025.01.23.634522.
Roback E, Ferrufino E, Moran R, Shennard D, Mulliniks C, Gallop J
Mol Biol Evol. 2025; 42(2).
PMID: 39833658
PMC: 11796094.
DOI: 10.1093/molbev/msaf012.
Li Q, Wu Y, Meng F, Li Z, Zhan D, Luo X
Orphanet J Rare Dis. 2025; 19(1):465.
PMID: 39789585
PMC: 11715027.
DOI: 10.1186/s13023-024-03430-4.
Gu L, Wu H, Liu T, Zhang Y, He J, Liu X
Nat Commun. 2025; 16(1):387.
PMID: 39755672
PMC: 11700122.
DOI: 10.1038/s41467-024-55496-0.
Exploring the therapeutic potential of modulating nonsense-mediated mRNA decay.
McMahon M, Maquat L
RNA. 2024; 31(3):333-348.
PMID: 39667907
PMC: 11874985.
DOI: 10.1261/rna.080334.124.
A W1282X cystic fibrosis mouse allows the study of pharmacological and gene-editing therapeutics to restore CFTR function.
Michicich M, Traylor Z, McCoy C, Valerio D, Wilson A, Schneider M
J Cyst Fibros. 2024; 24(1):164-174.
PMID: 39532588
PMC: 11788034.
DOI: 10.1016/j.jcf.2024.10.008.
A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint.
Kim Y, Kang H, Lee B, Jang H, Park J, Ha C
Commun Biol. 2024; 7(1):1461.
PMID: 39511375
PMC: 11544006.
DOI: 10.1038/s42003-024-07136-y.
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.
Puttick C, Jones T, Leung M, Galvez-Cancino F, Liu J, Varas-Godoy M
Nat Genet. 2024; 56(10):2121-2131.
PMID: 39358601
PMC: 11525181.
DOI: 10.1038/s41588-024-01883-8.
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.
Montero-Hidalgo A, Jimenez-Vacas J, Gomez-Gomez E, Porcel-Pastrana F, Saez-Martinez P, Perez-Gomez J
Sci Adv. 2024; 10(40):eado8231.
PMID: 39356765
PMC: 11446284.
DOI: 10.1126/sciadv.ado8231.
Dichotomous intronic polyadenylation profiles reveal multifaceted gene functions in the pan-cancer transcriptome.
Sun J, Kim J, Jun S, Park M, de Jong E, Chang J
Exp Mol Med. 2024; 56(10):2145-2161.
PMID: 39349823
PMC: 11541570.
DOI: 10.1038/s12276-024-01289-w.
Genotype-phenotype spectrum and correlation of PHARC Syndrome due to pathogenic ABHD12 variants.
Long X, Xiong W, Wang X, Geng J, Zhong M, Huang Y
BMC Med Genomics. 2024; 17(1):203.
PMID: 39123271
PMC: 11312174.
DOI: 10.1186/s12920-024-01984-7.
RNA variant assessment using transactivation and transdifferentiation.
Nicolas-Martinez E, Robinson O, Pflueger C, Gardner A, Corbett M, Ritchie T
Am J Hum Genet. 2024; 111(8):1673-1699.
PMID: 39084224
PMC: 11339655.
DOI: 10.1016/j.ajhg.2024.06.018.
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome.
Perge K, Capel E, Senee V, Julier C, Vigouroux C, Nicolino M
Rev Endocr Metab Disord. 2024; 25(5):827-838.
PMID: 39017987
PMC: 11470920.
DOI: 10.1007/s11154-024-09894-w.
Whole-genome sequencing identifies variants in ANK1, LRRN1, HAS1, and other genes and regulatory regions for stroke in type 1 diabetes.
Antikainen A, Haukka J, Kumar A, Syreeni A, Hagg-Holmberg S, Ylinen A
Sci Rep. 2024; 14(1):13453.
PMID: 38862513
PMC: 11166668.
DOI: 10.1038/s41598-024-61840-7.
X-chromosome inactivation in human iPSCs provides insight into X-regulated gene expression in autosomes.
Topa H, Benoit-Pilven C, Tukiainen T, Pietilainen O
Genome Biol. 2024; 25(1):144.
PMID: 38822397
PMC: 11143737.
DOI: 10.1186/s13059-024-03286-8.
Biosurfer for systematic tracking of regulatory mechanisms leading to protein isoform diversity.
Murali M, Saquing J, Lu S, Gao Z, Jordan B, Wakefield Z
bioRxiv. 2024; .
PMID: 38559226
PMC: 10980011.
DOI: 10.1101/2024.03.15.585320.
Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT.
Bernabeu-Herrero M, Patel D, Bielowka A, Zhu J, Jain K, Mackay I
Blood. 2024; 143(22):2314-2331.
PMID: 38457357
PMC: 11181359.
DOI: 10.1182/blood.2023021777.
Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders.
Shepard N, Baez-Nieto D, Iqbal S, Kurganov E, Budnik N, Campbell A
Sci Rep. 2024; 14(1):2798.
PMID: 38307912
PMC: 10837427.
DOI: 10.1038/s41598-024-53102-3.
Modulation of prion protein expression through cryptic splice site manipulation.
Gentile J, Corridon T, Mortberg M, DSouza E, Whiffin N, Minikel E
bioRxiv. 2024; .
PMID: 38187635
PMC: 10769280.
DOI: 10.1101/2023.12.19.572439.